Dr. Gish is a fellow of the American Association for the Study of Liver Disease, the American Society of Transplantation and American College of Physicians.

Professor Newsome runs the metabolic services at the Liver Unit at King's College Hospital London which includes a large multi-disciplinary clinic for patients with non-alcoholic fatty liver disease (NAFLD). He was Chief Investigator on a randomised controlled trial of Glucagon-like peptide-1 (GLP-1) therapies in NAFLD published in the Lancet and the NEJM. He is the Co-ordinating Investigator for several global NAFLD studies. He chaired the national guidelines for liver transplantation in NAFLD and sat on the NICE Guideline Development Group for NAFLD.

I am a transplant hepatologist at Oregon Health & Science University and a current AASLD CTORA awardee. I completed my gastroenterology and transplant hepatology fellowships at Massachusetts General Hospital. My research interests include dietary, behavioral, and metabolomic influences on MASLD and progression of liver disease. I am a former AASLD Emerging Liver Scholar and Ambassador.

Manal F. Abdelmalek, MD, MPH, FAASLD is a Professor of Medicine, Director of the Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Clinical Research Program at Mayo Clinic, Rochester, Minnesota. Her clinical and research area of interest has focused on NAFLD / NASH, associated risk factors for disease acquisition and progression and the discovery of novel approaches to treatment.

Dr. Chen is currently an Assistant Professor at the University of Michigan Medical School. He completed his undergraduate studies at Amherst College, followed by medical school at Harvard Medical School, residency at Stanford Healthcare, and gastroenterology/hepatology fellowships at the University of Michigan (completed June 2020). During fellowship, he obtained a Master in Science in Bioinformatics at University of Michigan. Dr.

Dr Muthiah is a Gastroenterologist and Hepatologist. He graduated from the Yong Loo Lin School of Medicine, National University of Singapore. He subsequently undertook specialist training in Internal Medicine, Gastroenterology, and Hepatology, graduating as the valedictorian of his cohort. He undertook further research training in Hepatology in Virginia Commonwealth University, USA under Prof Arun Sanyal.

Gyongyi Szabo, MD, PhD, FAASLD, AGAF, FACP


Gyongyi Szabo, MD, PhD is and the Mitchell T. Rabkin, M.D. Chair, Professor of Medicine and Faculty Dean at Harvard Medical School and Chief Academic Officer at the Beth Israel Deaconess Medical Center and Beth Israel Lahey Health.

Professor at Cedars-Sinai

Arpan Mohanty, MD, MSc is a hepatologist and Assistant Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine, where she directs Clinical Research in Gastroenterology & Hepatology at Boston Medical Center. Her work focuses on metabolic dysfunction–associated steatotic liver disease (MASLD), obesity-related liver disease, and advanced chronic liver disease. She leads multiple phase 2 and phase 3 clinical trials and develops innovative, equity-focused care models to improve early detection and management of liver disease in safety-net settings.